Soy Isoflavones 60 mg Veg Capsules

Soy Isoflavones 60 mg Veg Capsules

Product Description

  • May reduce severe and frequent menopausal symptoms (such as hot flashes and/or night sweats)
  • 60 mg of Isoflavones
  • Vegetarian / Vegan

Isoflavones are naturally occurring plant compounds that are particularly concentrated in soybeans.  Genistein, Daidzein and Glycitein are the major isoflavones found in soybeans.  NOW® Soy Isoflavones Veg Capsules have been extracted through a unique process that results in a higher level of Genistein - a quantum leap over most soy isoflavone products.

NPN 80016718

Available Quantities

Directions

Menopausal and/or post-menopausal women: For Reduction of Menopausal Symptoms: Take 1 capsule once daily a few hours before or after taking other medications or health care products. Use for a minimum of 2 weeks to see beneficial effects.

Ingredients

Each capsule contains:

Soy Isoflavone Extract (Glycine max (L.) Merr.) (Soybean) 150 mg
   Total Isoflavones 60 mg AIE*
   Genistein/genistin compounds 23.97 mg AIE*

*Aglycone Isoflavone Equivalents

Non-Medicinal Ingredients: Rice Flour, Veg Capsule (hypromellose, water), Silica, Magnesium Stearate (vegetable source).

Risk Information

Ensure you are up-to-date on mammograms and gynaecological evaluations prior to use. Consult a health care practitioner if symptoms worsen; if you are taking hormone replacement therapy (HRT), including thyroid hormone replacement therapy; if you have a history of hormonal or gynaecological disease including ovarian cancer, endometriosis, and/or uterine fibroids; if you have a liver disorder or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine); if you are taking blood thinners; and for use beyond 1 year. Discontinue use and consult a health care practitioner if you experience breast pain, discomfort and/or tenderness, or if you experience a recurrence of menstruation and/or uterine spotting. Do not use if you currently have or previously had breast cancer or if you have a predisposition to breast cancer as indicated by an abnormal mammogram and/or biopsy, or a family member with breast cancer.